Day 1

Intervenciones coronarias: optimizando la farmacología

solaci
solaci
533
0

simpfendorfer_conrad

Conrad Simpfendorfer.
2012-10-04

Previous article
¿Qué tanto nos adherimos a las guidelines AHA?
Next article
Enfermedad carótidea asintomática: Tratamiento Médico, Stenting o Endarterectomía?
solaci
solaci

More articles by this author

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Day 1

¿Qué tanto nos adherimos a las guidelines AHA?

Dario Echeverri 2012-10-04
solaci -
SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

Dr. Andrés Rodríguez - 0
The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Dr. Juan Manuel Pérez - 0
Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Coronary artery disease progression after transcatheter aortic valve replacement: quantitative coronary angiography and Quantitative Flow Ratio analysis

Dr. Juan Manuel Pérez - 0
The coexistence of coronary artery disease and severe aortic stenosis is common among patients undergoing transcatheter aortic valve replacement (TAVR). However, the impact of...